<DOC>
	<DOC>NCT01689857</DOC>
	<brief_summary>Compare the efficacy and safety of Scarclinic™Thin and Scarclinic™ Normal for the treatment of surgical scars. Participant: 40 Treatment period : 3 months Medical device: Scarclinic™Thin , Scarclinic™ Normal Randomization: Table of random number</brief_summary>
	<brief_title>Clinical Trial to Evaluate the Safety and Efficacy of Scarclinic™ Thin in Surgical Scars</brief_title>
	<detailed_description>For evaluating the efficacy - The investigator check Vancouver Scar Scale at 1 and 3 month after application to evaluate vascularity, pigmentation, elasticity, height, pain and itchiness - The participant filled out survey included questions regarding convenience in use at 1 and 3 month after application.</detailed_description>
	<mesh_term>Hypertrophy</mesh_term>
	<criteria>Patient who aged more than 18 years and less 55 years Patient who has a surgical scar that is not over 3 months after the surgery Patient who sign informed consent form for the study need wound dressing for exudate wound infection general malaise history of mental disorders taking anticancer drugs or antiphlogistics or steroid</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>hypertropic scar, Vancouver scar scale, silicon gel sheet</keyword>
</DOC>